Comparison results
| Results: Differences General | ✘Erythrocytic anemia | ✘Kimura's disease | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 73% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
| aplasia of the thymus | 64% | — | ||||||||||
| drug-induced dermatitis | — | 38% | ||||||||||
| thymoma | 57% | — | ||||||||||
| hay fever asthma | — | 36% | ||||||||||
| aplastic anemia | 48% | — | ||||||||||
| atopic bronchial asthma | — | 30% | ||||||||||
| anemia | 41% | — | ||||||||||
| a bump on the head | — | 29% | ||||||||||
| antibodies to smooth muscle | 36% | — | ||||||||||
| seasonal allergies | — | 28% | ||||||||||
| erythrocytic anemia | 34% | — | ||||||||||
| allergic rhinitis | — | 27% | ||||||||||
| malignant lymphoma | 32% | — | ||||||||||
| eosinophilia | — | 25% | ||||||||||
| reticulocytopenia | 32% | — | ||||||||||
| respiratory allergy | — | 24% | ||||||||||
| leukemia | 32% | — | ||||||||||
| atopic dermatitis | — | 24% | ||||||||||
| lymphoma | 31% | — | ||||||||||
| allergy to the skin | — | 23% | ||||||||||
| chronic lymphocytic | 29% | — | ||||||||||
| exanthema | — | 23% | ||||||||||
| increased gamma globulins | 29% | — | ||||||||||
| chronic granulomatous disease | — | 23% | ||||||||||
| lymphocytic | 28% | — | ||||||||||
| allergic rash | — | 23% | ||||||||||
| non-Hodgkin's lymphoma | 27% | — | ||||||||||
| common rashes | — | 22% | ||||||||||
| myeloma | 26% | — | ||||||||||
| bronchial asthma | — | 22% | ||||||||||
| erythropenia | 26% | — | ||||||||||
| enlarged lymph nodes | — | 22% | ||||||||||
| parvovirus infection | 26% | — | ||||||||||
| inflammation | — | 22% | ||||||||||
| connective tissue dysplasia | 26% | — | ||||||||||
| skin spots | — | 20% | ||||||||||
| splenectomy | 26% | — | ||||||||||
| dermatitis | — | 20% | ||||||||||
| solid tumor | 25% | — | ||||||||||
| oncology | 2% | 22% | ||||||||||
| lymphocytosis | 24% | — | ||||||||||
| lymph node damage | — | 20% | ||||||||||
| enlargement of the spleen | 22% | — | ||||||||||
| radiation therapy | — | 19% | ||||||||||
| cancer in the anamnesis | 22% | — | ||||||||||
| leukocytosis | — | 19% | ||||||||||
| chronic anemia | 22% | — | ||||||||||
| papules | — | 19% | ||||||||||
| cancer | 39% | 17% | ||||||||||
| radiation damage | — | 18% | ||||||||||
| immunodeficiency | 19% | — | ||||||||||
| angiopathy | — | 17% | ||||||||||
| a lot of medicines | 19% | — | ||||||||||
| consequences of taking medications | — | 16% | ||||||||||
| increased bleeding | 19% | — | ||||||||||
| patient's condition | — | 15% | ||||||||||
| there are no complaints | 17% | — | ||||||||||
| history of surgery | — | 15% | ||||||||||
| drug allergy | 19% | 26% | ||||||||||
| skin problems | 16% | 23% | ||||||||||
| allergy | 18% | 25% | ||||||||||
| drug disease | 17% | 23% | ||||||||||
| increased | 21% | 26% | ||||||||||
| gradual deterioration of the condition | 19% | 19% | ||||||||||
| delayed reaction | 23% | 23% | ||||||||||
| increased sensitivity | 18% | 18% | ||||||||||
| oncology in the anamnesis | 20% | 20% | ||||||||||
Instructions
Video
|